“Once-weekly efsitora administered in a fixed-dose regimen was noninferior to once-daily glargine in reducing glycated hemoglobin levels at 52 weeks,” the authors write.

UFC is providing fans with a free stream to watch along with their monumental UFC 317 event tonight.

"Once-weekly efsitora administered in a fixed-dose regimen was noninferior to once-daily glargine in reducing glycated hemoglobin levels at 52 weeks," the authors write.

With detailed readouts from a suite of late-stage trials, Eli Lilly is heading to regulators with its once-a-week insulin asset efsitora alfa.

Eli Lilly's orforglipron reduced A1C and weight in type 2 diabetes, while weekly insulin efsitora matched daily insulin with fewer side effects.

Once-Weekly Basal Insulin Non-Inferior to Several Daily Options in Type 2 Diabetes — Insulin efsitora may potentially change the management paradigm, researcher says ...

The trial randomized 795 participants across the U.S., Argentina and Mexico to receive efsitora once weekly or insulin glargine once daily, administered subcutaneously.

Initiation of longer-acting insulins, such as glargine or degludec, administered at bedtime, has gained widespread use and is effective in lowering glycated hemoglobin levels; however, daily ...

More than three years after approving two biosimilars referencing Sanofi’s long-acting insulin Lantus, the FDA has signed off on a rapid-acting insulin biosimilar for the first time. | The FDA ...

Samsung Bioepis' Q1 2025 report shows oncology, ophthalmology, and pegfilgrastim biosimilars have gained significant market share, while immunology, filgrastim, epoetin alfa, and insulin glargine ...

Levemir is a prescription drug used for diabetes. Find out about possible interactions with alcohol, other drugs, supplements, foods, and more.